Table 2.

Demographics and clinical measurements of drug free patients with paranoid schizophrenia compared with control subjects which were closely matched for BMI and smoking habits. Annotation: data are given as mean ± standard deviation (SD), n.a. = not applicable, ^aANOVA, ^bChi-square-test, ↑↓ positive or negative influence on measures, bold P-values were significant.

Demographic data	Controls (n = 11)	Paranoid schizophrenia: drug free (n = 11)	Schizophrenia versus controls P-values
Age [y]	34.7 ± 12.0	35.1 ± 13.2	0.947a
Duration of disease [y]	—	8.5 ± 10.8	—
Male/Female [n]	7/4	7/4	1.000b
BMI [kg/m2]	23.5 ± 3.4	24.5 ± 5.5	0.621a
Smokers/non-smokers [n]	6/5	7/4	0.665b
Measures	Mean ± SD	Mean ± SD
S100B [μg/L]	0.046 ± 0.014	0.073 ± 0.033	0.028a↑
hs-CRP [mg/L]	1.47 ± 1.64	2.50 ± 2.51	0.267a
TNF-α [ng/L]	2.51 ± 1.95	2.95 ± 1.79	0.584a
Leptin [μg/L]	11.82 ± 16.91	13.74 ± 12.49	0.766a
MCP-1 [ng/L]	314.9 ± 190.0	308.8 ± 166.2	0.936a
HGF [μg/L]	2.32 ± 1.85	2.84 ± 2.11	0.543a
Resistin [μg/L]	5.71 ± 1.80	6.70 ± 1.83	0.214a
PAI-1 [μg/L]	1.49 ± 0.75	2.30 ± 1.55	0.139a
Triglycerides [mg/dL]	144.3 ± 47.2	205.6 ± 102.3	0.093a↑
Glucose [mg/dL]	81.1 ± 12.2	105.7 ± 25.0	0.011a↑
C-peptide [pmol/L]	1219.0 ± 680.1	2760.3 ± 1657.0	0.013a↑